Trump Administration Aims to Cut Medicaid Funding for Immigrants, Endangering California's $12 Billion Program
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
Medicaid Spending Probes: The Trump administration is investigating Medicaid spending in California and five other Democratic-led states, focusing on potential waste and fraud in healthcare services for immigrants without permanent legal status.
California's Program Under Scrutiny: California's Medi-Cal program, which provides healthcare to 1.6 million undocumented immigrants, faces scrutiny after reporting $500 million in improper federal billings, with potential enforcement actions from CMS if violations are confirmed.
Analyst Views on XLV
Wall Street analysts forecast XLV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XLV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 158.290
Low
Averages
High
Current: 158.290
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
